COMMUNIQUÉS West-GlobeNewswire

Precipio Appoints Samuel D. Riccitelli as Chairman of the Board of Directors and Elects David Cohen as Director

14/11/2017 - 22:15

NEW HAVEN, Conn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), today announced that on November 8, 2017, Precipio’s Board of Directors (the “Board”) appointed Samuel D. Riccitelli as Chairman, [...]

Asterias Biotherapeutics Reports Third Quarter Financial Results and Recent Developments

14/11/2017 - 22:10

- Continues to execute on key clinical programs and streamline cost structure - - Conference call and webcast today, November 14, at 4:30 p.m. ET - FREMONT, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Asterias [...]

HealthEquity Sets Date to Announce Third Quarter Results

14/11/2017 - 22:05

DRAPER, Utah, Nov. 14, 2017 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the largest HSA non-bank custodian, today announced that it plans to release its third quarter of [...]

aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update

14/11/2017 - 22:05

- Initiation of Phase 1 clinical trial of iMod.Fc on-track for this quarter - - Selection of antibody for ORCA program on-track for this quarter - SAN DIEGO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: [...]

Evoke Pharma Reports Third Quarter 2017 Results and Highlights

14/11/2017 - 22:05

Announced positive topline results from comparative exposure pharmacokinetic (PK) trial for Gimoti™ 505(b)(2) New Drug Application (NDA) submission on track for Q1 2018 filing Partnered with the Patheon division of [...]

Entellus Medical to Participate in Upcoming Investor Conferences

14/11/2017 - 22:05

PLYMOUTH, Minn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ: ENTL ), a medical technology company focused on delivering minimally invasive ENT procedures, today announced the Company plans to [...]

Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference

14/11/2017 - 22:05

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in [...]

Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update

14/11/2017 - 22:05

RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced [...]

Achillion Announces Proposed Secondary Offering of Common Stock

14/11/2017 - 22:03

NEW HAVEN, Conn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (“Achillion”) (NASDAQ: ACHN ) today announced that Johnson & Johnson Innovation-JJDC, Inc. (“JJDC”), an existing stockholder of [...]

Aptevo Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference

14/11/2017 - 22:02

SEATTLE, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that management will be [...]

Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results

14/11/2017 - 22:01

Completed Merger with Threshold Pharmaceuticals in August Recent Equity Financings of $60 Million Provide Cash Runway into late 2019 MT-3724 Advancing in Clinical Trials with New Data Expected in 1H18 AUSTIN, Texas, Nov [...]

Invuity to Present at Upcoming Investor Conferences

14/11/2017 - 22:01

SAN FRANCISCO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to attend the [...]

Achillion Reports Preliminary Proof-of-Concept With ACH-4471 for the Treatment of C3G

14/11/2017 - 22:01

- Greater than 50% improvement in proteinuria (albumin to creatinine ratio) after 14 days of oral dosing with ACH-4471 - - Improvement in complement alternative pathway biomarkers observed - NEW HAVEN, Conn., Nov. 14, [...]

Aptose Reports Results for the Third Quarter Ended September 30, 2017

14/11/2017 - 22:00

SAN DIEGO and TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that [...]

Southern Vein & Laser Center Announces Grand Opening of New Atlanta Location

14/11/2017 - 21:25

ATLANTA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Southern Vein & Laser Center is pleased to announce the grand opening of their new Atlanta office in Buckhead. On September 8, 2017, Dr. Richard Ambrozic held a public [...]

Spine Injury Solutions Inc. Announces Las Cruces, NM Affiliate under its new Affiliate Expansion Program

14/11/2017 - 21:11

HOUSTON, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, and healthcare solution company servicing the multi-billion dollar spine injury sector, today [...]

Genmab Achieves USD 25 Million Milestone for First Commercial Sale of DARZALEX® (daratumumab) in Japan and Updates Financial Guidance

14/11/2017 - 20:49

Company Announcement First commercial sale of DARZALEX in Japan triggers USD 25 million in milestone payments from Janssen Financial guidance updated Copenhagen, Denmark; November 14, 2017 – Genmab A/S (Nasdaq [...]

Pacific Health Care Organization, Inc. Reports Third Quarter 2017 Results

14/11/2017 - 19:05

NEWPORT BEACH, Calif., - , Nov. 14, 2017 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its quarterly [...]

Capital Increase in Genmab as a Result of Employee Warrant Exercise

14/11/2017 - 18:19

Company Announcement Copenhagen, Denmark; November 14, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 22,532 shares as a consequence of the exercise of employee warrants. The increase is [...]